Global Kidney Cancer Radiation Therapies and Epidemiology - 2016

  • ID: 3692211
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Kidney Cancer Radiation Therapies and Epidemiology – 2016, provides insights into total Kidney Cancer patients on radiation therapies in top 7 markets, Kidney Cancer treatable patients, and Kidney Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Kidney Cancer specialists, oncologists, and Kidney Cancer patients to identify the Kidney Cancer patients in top 7 markets who were treated by radiation therapies. The research also identifies total Kidney Cancer patients’ on radiation therapies by Kidney Cancer stages.
The external beam therapy, focuses radiation from a source outside the patients body on the cancer. Kidney cancers patients are not very sensitive to radiation and used to treat kidney cancer if a patients is not healthy enough to have other treatments. This study accurately determines and forecast Kidney Cancer patients who were on radiation therapies in a given year. This research also provides insights into Kidney Cancer epidemiology including Kidney Cancer incidence and Kidney Cancer prevalence by Kidney Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Kidney Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Kidney Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Kidney Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Kidney Cancer Patients on radiation therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Kidney Cancer market potential, Kidney Cancer radiation therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Kidney Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on Radiation Therapies
3. Kidney Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on Radiation Therapies
4. Kidney Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on Radiation Therapies
5. Kidney Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on Radiation Therapies
6. Kidney Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on Radiation Therapies
7. Kidney Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on Radiation Therapies
8. Kidney Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on Radiation Therapies
9. Kidney Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on Radiation Therapies
10. Glossary

1. Kidney Cancer Incidence by Stages, Global, 2010 - 2025
2. Kidney Cancer Prevalence by Stages, Global, 2010 - 2025
3. Kidney Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Kidney Cancer Patients on Radiation Therapies by Stages, Global, 2010 – 2025
5. Kidney Cancer Incidence by Stages, Germany, 2010 - 2025
6. Kidney Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Kidney Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Kidney Cancer Patients on Radiation Therapies by Stages, Germany, 2010 - 2025
9. Kidney Cancer Incidence by Stages, France, 2010 - 2025
10. Kidney Cancer Prevalence by Stages, France, 2010 - 2025
11. Kidney Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Kidney Cancer Patients on Radiation Therapies by Stages, France, 2010 - 2025
13. Kidney Cancer Incidence by Stages, Italy, 2010 - 2025
14. Kidney Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Kidney Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Kidney Cancer Patients on Radiation Therapies by Stages, Italy, 2010 - 2025
17. Kidney Cancer Incidence by Stages, Spain, 2010 - 2025
18. Kidney Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Kidney Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Kidney Cancer Patients on Radiation Therapies by Stages, Spain, 2010 - 2025
21. Kidney Cancer Incidence by Stages, UK, 2010 - 2025
22. Kidney Cancer Prevalence by Stages, UK, 2010 - 2025
23. Kidney Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Kidney Cancer Patients on Radiation Therapies by Stages, UK, 2010 – 2025
25. Kidney Cancer Incidence by Stages, Japan, 2010 - 2025
26. Kidney Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Kidney Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Kidney Cancer Patients on Radiation Therapies by Stages, Japan, 2010 – 2025
29. Kidney Cancer Incidence by Stages, US, 2010 - 2025
30. Kidney Cancer Prevalence by Stages, US, 2010 - 2025
31. Kidney Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Kidney Cancer Patients on Radiation Therapies by Stages, US, 2010 - 2025

1. Kidney Cancer Incidence, Global, 2010 – 2025
2. Kidney Cancer Incidence – Stage I, Global, 2010 – 2025
3. Kidney Cancer Incidence – Stage II, Global, 2010 - 2025
4. Kidney Cancer Incidence – Stage III, Global, 2010 - 2025
5. Kidney Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Kidney Cancer Prevalence, Global, 2010 - 2025
7. Kidney Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Kidney Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Kidney Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Kidney Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Kidney Cancer Treatable Patients, Global, 2010 - 2025
12. Kidney Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Kidney Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Kidney Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Kidney Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Kidney Cancer Patients on Radiation Therapies, Global, 2010 - 2025
17. Total Kidney Cancer Patients on Radiation Therapies – Stage I, Global, 2010 – 2025
18. Total Kidney Cancer Patients on Radiation Therapies – Stage II, Global, 2010 – 2025
19. Total Kidney Cancer Patients on Radiation Therapies – Stage III, Global, 2010 – 2025
20. Total Kidney Cancer Patients on Radiation Therapies – Stage IV, Global, 2010 – 2025
21. Kidney Cancer Incidence by Stages, Germany, 2010 – 2025
22. Kidney Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Kidney Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Kidney Cancer Patients on Radiation Therapies, Germany, 2010 - 2015
25. Kidney Cancer Incidence by Stages, France, 2010 – 2025
26. Kidney Cancer Prevalence by Stages, France, 2010 – 2025
27. Kidney Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Kidney Cancer Patients on Radiation Therapies, France, 2010 – 2025
29. Kidney Cancer Incidence by Stages, Italy, 2010 – 2025
30. Kidney Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Kidney Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Kidney Cancer Patients on Radiation Therapies, Italy, 2010 – 2025
33. Kidney Cancer Incidence by Stages, Spain, 2010 – 2025
34. Kidney Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Kidney Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Kidney Cancer Patients on Radiation Therapies, Spain, 2010 - 2015
37. Kidney Cancer Incidence by Stages, UK, 2010 – 2025
38. Kidney Cancer Prevalence by Stages, UK, 2010 – 2025
39. Kidney Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Kidney Cancer Patients on Radiation Therapies, UK, 2010 – 2025
41. Kidney Cancer Incidence by Stages, Japan, 2010 – 2025
42. Kidney Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Kidney Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Kidney Cancer Patients on Radiation Therapies, Japan, 2010 – 2025
45. Kidney Cancer Incidence by Stages, US, 2010 – 2025
46. Kidney Cancer Prevalence by Stages, US, 2010 – 2025
47. Kidney Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Kidney Cancer Patients on Radiation Therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll